Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01882816 · ClinicalTrials.gov registry record · Phase 2
Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT01882816: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01882816 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01882816, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this Phase 2 study is to find out what effect, good and/or bad, external beam radiation therapy, has on the patient and their thyroid cancer where surgery is not an option or where despite surgery, the disease is still present.
Interventions
- DRUG Doxorubicin
- RADIATION IMRT
- DEVICE DWI MRI
- OTHER Modified Barium Swallow Impairment Profile (MBSImP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2013-06-13 |
| Est. Completion | 2021-11-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01882816
The ClinicalTrials.gov registry entry for NCT01882816 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Doxorubicin is the first listed.
NCT01882816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01882816 about?
NCT01882816 is a clinical study titled "Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer". The purpose of this Phase 2 study is to find out what effect, good and/or bad, external beam radiation therapy, has on the patient and their thyroid cancer where surgery is not an option or where despite surgery, the disease is still present.
What is the current status of trial NCT01882816?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2013-06-13. Estimated completion is 2021-11-04.
What interventions are being tested in trial NCT01882816?
The interventions under investigation include: Doxorubicin (DRUG), IMRT (RADIATION), DWI MRI (DEVICE), Modified Barium Swallow Impairment Profile (MBSImP) (OTHER).
Who is sponsoring clinical trial NCT01882816?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.